Y-134 (Raloxifene Analog)
Shop Y-134 (Raloxifene Analog) on KimeraChems · code GUIDE (10% off)Definition
Y-134 is a research compound positioned as a raloxifene analog and commonly discussed within the broader selective estrogen receptor modulator (SERM) class. In research contexts, it is typically explored as a tool for modulating estrogen-receptor signaling with tissue-selective activity. Its downstream effects may therefore differ across tissues based on receptor-subtype expression, cofactor availability, and baseline endocrine conditions. Because Y-134 is referenced as a raloxifene analog, it is generally studied for estrogen-receptor-modulation patterns that may resemble raloxifene-like signaling profiles in certain experimental designs rather than for direct estrogen-agonist activity.
Available Formats
- Dry-fill capsules (commonly 10 mg per capsule, 60-count / 600 mg total)
- 30 mL liquid solution (20 mg per mL / 600 mg total)
- 1 gram powder
Mechanism of Action
Research discussions suggest Y-134 may: As with other SERM-class compounds, observed outcomes are highly dependent on tissue type, species, receptor-subtype distribution, and baseline estrogen signaling.
- Bind estrogen receptors and alter receptor conformation
- Modulate estrogen-responsive transcription in a tissue-selective manner
- Display context-dependent agonist or antagonist activity depending on model design
- Influence estrogen-receptor coactivator and corepressor recruitment
- Alter estrogen-driven signaling endpoints, including proliferation markers and gene-expression signatures, in estrogen-receptor-sensitive systems
Areas of Investigation
Y-134 is commonly studied in
- Estrogen-receptor-signaling models involving ER-alpha and ER-beta pathway mapping
- Comparative SERM research involving raloxifene-class compounds and other estrogen-receptor modulators
- Gene-expression studies in which estrogen-receptor-regulated transcription is a key variable
- Tissue-selective endocrine-signaling paradigms
- Bone, lipid, and metabolic-endpoint models in which estrogen signaling is part of the mechanistic hypothesis
- Receptor-binding and functional-assay development
Safety Profile
Reported observations associated with SERM-class research compounds may include
- Hot-flash-like thermoregulatory effects in sensitive models
- Headache-like effects
- Mood lability or sleep-disruption signals in sensitive settings
- Gastrointestinal discomfort
- Changes in liver-associated biomarkers in some study designs
- Thromboembolic-risk signals associated with the broader SERM class, treated as a conservative monitoring consideration in longer-duration designs
Interaction Notes
Y-134 is often discussed alongside compounds and variables that influence endocrine-signaling endpoints
For educational purposes only. Not for human consumption.